The first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates, specifically targeting KRAS inhibitors for cancer therapy. With our partners, we designed, selected, and synthesized 15 proposed molecules, with two holding promise for future development.
Search research literature for relevant studies.
Develop new techniques for exploring the space of protein configurations.
Generate novel molecular structures and drug candidates with specific functionalities.
Optimize the sequence of amino acid–rotamers in a protein active site to improve the functionality and minimize the energy function, without altering the backbone structure.
Accelerate genomic sequencing to reduce the dimensionality of the genome space.
Get to better trial outcomes, faster. Identify the patient features that will drive the greatest chance for effective treatment and the lowest risk of counter-indications.
Simplify large quantities of clinical trial data to improve ML models used to analyze the data.
Analyze clinical trial data to identify the right dosage for different patient groups.
Augment limited clinical trial datasets with synthetic data to generate more conclusive insights.
Optimize suppliers and vendors selection, and transportation planning to minimize costs.
Optimize the production scheduling of many pharmaceutical products and medical devices to unlock new efficiencies, saving time and reducing costs.
Optimize resource allocation for marketing, production, and distribution decisions during the launch of new drugs.
Optimize ad targeting to reach the patients most likely to be in the market for a specific medical treatment.
Classify medical data, such as MRI scans, to assist diagnostics that may be more compact and accurate than purely classical models.
Optimize healthcare resource allocation by prioritizing scheduling for doctors and therapies and matching patients to appropriate treatments.
Optimize the scheduling, staffing, and distribution of ambulances to support population health needs.
Optimize radiotherapy dosages to maximize therapeutic benefit while minimizing harmful side effects
Optimize radiotherapy dosages to maximize therapeutic benefit while minimizing harmful side effects
